lobbying_activities: 2465850

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2465850	b43efa7c-6cd5-43a1-b394-cc1ea7e5b51e	Q2	WINNING STRATEGIES WASHINGTON	50796	KALEO	2020	second_quarter	PHA	Pharmaceutical drug development, including epinephrine for anaphlylaxis; drug access and affordability issues	Federal Aviation Administration (FAA),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2020-07-15T10:48:06.507000-04:00